Evidence map›Paper›PMID 36413918›Full record

ArticleRedox biology2022

Inhibition of ferroptosis promotes retina ganglion cell survival in experimental optic neuropathies.

Miao Guo, Yanfang Zhu, Ying Shi, Xiangda Meng, Xue Dong, Haokun Zhang, Xiaohong Wang, Mei Du, Hua Yan

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. GPX4 promotes optic nerve regeneration and retinal ganglion cell neuroprotection.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Ferroptosis: A Novel Mechanism in Diabetic Keratopathy.Investigative ophthalmology & visual science · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Piperine alleviates retinal ischemic injury by mediating the APE1 signaling.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Miao GuoDepartment of Ophthalmology, Tianjin Medical University General Hospital, 300052, Tianjin, China; Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Tianjin Medical University, 300070, Tianjin, China.
Yanfang ZhuDepartment of Ophthalmology, Tianjin Medical University General Hospital, 300052, Tianjin, China; Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Tianjin Medical University, 300070, Tianjin, China.
Ying ShiDepartment of Ophthalmology, Tianjin Medical University General Hospital, 300052, Tianjin, China; Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Tianjin Medical University, 300070, Tianjin, China; Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University, 300070, Tianjin, China.
Xiangda MengDepartment of Ophthalmology, Tianjin Medical University General Hospital, 300052, Tianjin, China; Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Tianjin Medical University, 300070, Tianjin, China.
Xue DongDepartment of Ophthalmology, Tianjin Medical University General Hospital, 300052, Tianjin, China; Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Tianjin Medical University, 300070, Tianjin, China.
Haokun ZhangDepartment of Ophthalmology, Tianjin Medical University General Hospital, 300052, Tianjin, China; Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Tianjin Medical University, 300070, Tianjin, China.
Xiaohong WangDepartment of Ophthalmology, Tianjin Medical University General Hospital, 300052, Tianjin, China; Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Tianjin Medical University, 300070, Tianjin, China; Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University, 300070, Tianjin, China. Electronic address: xiaohongwang@tmu.edu.cn.
Mei DuDepartment of Ophthalmology, Tianjin Medical University General Hospital, 300052, Tianjin, China; Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Tianjin Medical University, 300070, Tianjin, China; Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University, 300070, Tianjin, China. Electronic address: dumei@tmu.edu.cn.
Hua YanDepartment of Ophthalmology, Tianjin Medical University General Hospital, 300052, Tianjin, China; Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Tianjin Medical University, 300070, Tianjin, China; School of Medicine, Nankai University, 300071, Tianjin, China. Electronic address: zyyyanhua@tmu.edu.cn.
Tianjin Medical University · CNTianjin Medical University General Hospital · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinal ganglion cell (RGC) death is a hallmark of traumatic optic neuropathy, glaucoma, and other optic neuropathies that result in irreversible vision loss. However, therapeutic strategies for rescuing RGC loss still remain challenging, and the molecular mechanism underlying RGC loss has not been fully elucidated. Here, we highlight the role of ferroptosis, a non-apoptotic form of programmed cell death characterized by iron-dependent lethal lipid peroxides accumulation, in RGC death using an experimental model of glaucoma and optic nerve crush (ONC). ONC treatment resulted in significant downregulation of glutathione peroxidase 4 (GPx4) and system xc(-) cystine/glutamate antiporter (xCT) in the rat retina, accompanied by increased lipid peroxide and iron levels. The reduction of GPx4 expression in RGCs after ONC was confirmed by laser-capture microdissection and PCR. Transmission electron microscopy (TEM) revealed alterations in mitochondrial morphology, including increased membrane density and reduced mitochondrial cristae in RGCs after ONC. Notably, the ferroptosis inhibitor ferrostatin-1 (Fer-1) significantly promoted RGC survival and preserved retinal function in ONC and microbead-induced glaucoma mouse models. In addition, compared to the apoptosis inhibitor Z-VAD-FMK, Fer-1 showed better effect in rescuing RGCs death in ONC retinas. Mechanistically, we found the downregulation of GPx4 mainly occurred in the mitochondrial compartment, accompanied by increased mitochondrial reactive oxygen species (ROS) and lipid peroxides. The mitochondria-selective antioxidant MitoTEMPO attenuated RGC loss after ONC, implicating mitochondrial ROS and lipid peroxides as major mechanisms in ferroptosis-induced RGC death in ONC retinas. Notably, administering Fer-1 effectively prevented the production of mitochondrial lipid peroxides, the impairment of mitochondrial adenosine 5'-triphosphate (ATP) production, and the downregulation of mitochondrial genes, such as mt-Cytb and MT-ATP6, in ONC retinas. Our findings suggest that ferroptosis is a major form of regulated cell death for RGCs in experimental glaucoma and ONC models and suggesting targeting mitochondria-dependent ferroptosis as a protective strategy for RGC injuries in optic neuropathies.

Indexed as

FerroptosisGlaucomaOptic Nerve InjuriesAnimalsCell SurvivalDisease Models, AnimalIronLipid PeroxidesMiceRatsReactive Oxygen SpeciesRetinaRetinal Ganglion CellsIronLipid PeroxidesReactive Oxygen SpeciesFerroptosisGlutathione peroxidase 4Mitochondrial ROSOptic neuropathiesRetinal ganglion cells

Identifiers

PMID36413918
PMCPMC9679710
OpenAlexW4308987272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.